相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
Andrew H. Wei et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Recent advances in the development of Mcl-1 inhibitors for cancer therapy
Alexander W. Hird et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Venetoclax in the treatment of chronic lymphocytic leukemia
Anna Korycka-Wolowiec et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Xufeng Chen et al.
CANCER DISCOVERY (2019)
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression
Guo Chen et al.
CANCER RESEARCH (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy
Guo Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
T-C Teh et al.
LEUKEMIA (2018)
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Steven Coutre et al.
BLOOD (2018)
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Stephan Stilgenbauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
FBXW7: a critical tumor suppressor of human cancers
Chien-Hung Yeh et al.
MOLECULAR CANCER (2018)
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Haley E. Ramsey et al.
CANCER DISCOVERY (2018)
Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives
Insa Schiffmann et al.
EPIGENETICS (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epigenetics in non-small cell lung cancer: from basics to therapeutics
Junaid Ansari et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia
Rongqing Pan et al.
BLOOD (2015)
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy
Bingshe Han et al.
CANCER CELL (2015)
MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
G. S. Choudhary et al.
CELL DEATH & DISEASE (2015)
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis
B. Wang et al.
CELL DEATH AND DIFFERENTIATION (2014)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Epigenetic therapy of non-small cell ung cancer using decitabine (5-aza-2'-deoxycytidine)
Richard L. Momparler
FRONTIERS IN ONCOLOGY (2013)
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Sonal Gupta et al.
CLINICAL CANCER RESEARCH (2012)
Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells
Yan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Detection of methylation of the RAR-β gene in patients with non-small cell lung cancer
Xudong Zhao et al.
ONCOLOGY LETTERS (2012)
Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines
Jianzhen Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA
Barbora Brodska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells
Mingmei Liao et al.
MOLECULAR CANCER (2011)
Simultaneous inhibition of DNA methyltransferase and histone deacetylase induces p53-independent apoptosis via down-regulation of Mcl-1 in acute myelogenous leukemia cells
Chie Nishioka et al.
LEUKEMIA RESEARCH (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
H. Zhang et al.
ONCOGENE (2011)
Ubiquitin: Same Molecule, Different Degradation Pathways
Michael J. Clague et al.
CELL (2010)
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance
Masaaki Iwatsuki et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inactivation of FBXW7/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer
Shahab Akhoondi et al.
BREAST CANCER RESEARCH (2010)
The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer
Roland P. Kuiper et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells
Y. Saito et al.
ONCOGENE (2009)
The Fbxw7/hCdc4 tumor suppressor in human cancer
YingMeei Tan et al.
CANCER LETTERS (2008)
Enhancing mammalian target of rapamycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR/rictor-independent Akt activation
Xuerong Wang et al.
CANCER RESEARCH (2008)
Lung cancer epigenetics and genetics
Angela Risch et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
Paul P. Anglim et al.
MOLECULAR CANCER (2008)
FBXW7/hCDC4 is a general tumor suppressor in human cancer
Shahab Akhoondi et al.
CANCER RESEARCH (2007)
Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity
Joshua P. Cantor et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
David S. Schrump et al.
CLINICAL CANCER RESEARCH (2006)
Protein phosphatase 2A regulatory subunit b56α associates with c-Myc and negatively regulates c-Myc accumulation
HK Arnold et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1
U Maurer et al.
MOLECULAR CELL (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
JT Opferman et al.
NATURE (2003)
分享论文
